The role of PSMA radioligands in the diagnosis and treatment of prostate carcinoma.
Auteurs : Rodríguez-Fraile M, Tamayo Alonso P, Rosales JJ, de Arcocha-Torres M, Caresia-Aróztegui AP, Cózar-Santiago MP, Orcajo-Rincon J, Simó Perdigó M, Delgado Bolton RC, Artigas C Jaar : 2022 Journal : Rev Esp Med Nucl Imagen Mol (Engl Ed)
Targeted radionuclide therapy: an emerging field in solid tumours.
Auteurs : Artigas C, Mileva M, Flamen P, Karfis I Jaar : 2021 Journal : Curr Opin Oncol
The Role of Prostate-specific Membrane Antigen Positron Emission Tomography/Magnetic Resonance Imaging in Primary and Recurrent Prostate Cancer: A Systematic Review of the Literature.
Auteurs : Manfredi C, Fernández-Pascual E, Arcaniolo D, Emberton M, Sanchez-Salas R, Artigas C, Bianco F, Cathcart P, Murphy DG, Couñago F, Martínez-Ballesteros C, Verze P, Martínez-Salamanca JI Jaar : 2021 Journal : Eur Urol Focus
Oligometastatic Disease Detection with <sup>68</sup>Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer Patients (HSPC) with Biochemical Recurrence after Radical Prostatectomy: Predictive Factors and Clinical Impact.
Auteurs : Artigas C, Diamand R, Shagera QA, Plouznikoff N, Fokoue F, Otte FX, Gil T, Peltier A, Van Gestel D, Flamen P Jaar : 2021 Journal : Cancers (Basel)
<sup>68</sup>Ga-PSMA PET/CT for response assessment and outcome prediction in metastatic prostate cancer patients treated with taxane-based chemotherapy.
Auteurs : Shagera QA, Artigas C, Karfis I, Critchi G, Martinez Chanza N, Sideris S, Peltier A, Paesmans M, Gil T, Flamen P Jaar : 2021 Journal : J Nucl Med